Market Overview

UPDATE: Credit Suisse Raises PT on Medidata Solutions Following 1Q13 Results

Related MDSO
Hold On Teladoc Bulls: Stifel Is Cautious Amid Business Model Uncertainty
Top 4 Mid-Cap Stocks In The Healthcare Information Services Industry With The Highest EPS Growth Forecast For Next 5 Years

In a report published Tuesday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on Medidata Solutions (NASDAQ: MDSO), and raised the price target from $75.00 to $80.00.

In the report, Credit Suisse noted, “On the back of MDSO's 1Q13 results, continued benefit from competitive market share gains and further evidence of the company's ability to grow its wallet share within its new and existing customer base. In this report we attempt to provide a different valuation framework for the company given our understanding of the preferred valuation metrics for the Healthcare Services investor vs. the valuation metrics most relevant to ‘cloud companies.'”

Medidata Solutions closed on Monday at $69.87.

Latest Ratings for MDSO

Oct 2015Topeka CapitalUpgradesHoldBuy
Oct 2015Stifel NicolausMaintainsBuy
Apr 2015JefferiesDowngradesBuyHold

View More Analyst Ratings for MDSO
View the Latest Analyst Ratings

Posted-In: Credit Suisse Glen SantangeloAnalyst Color Price Target Analyst Ratings


Related Articles (MDSO)

View Comments and Join the Discussion!

Get Benzinga's Newsletters